• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超越体重减轻:探索减肥手术后胆汁酸的调节及其对2型糖尿病的5年影响。

Beyond weight loss: exploring bile acid modulations after bariatric surgery and their impact on type 2 diabetes across 5 years.

作者信息

Yang John Zhiyong, Li Michelle, Zhou Weiyu, Nemati Reza, Jin Xiaodong, Plank Lindsay D, Murphy Rinki, Lu Jun

机构信息

Quzhou Eco-Industrial Innovation Institute, Zhejiang University of Technology Hangzhou, Zhejiang, China.

Department of Food and Agriculture Technology, Yangtze Delta Region Institute of Tsinghua University, Jiaxing, China.

出版信息

Obesity (Silver Spring). 2025 Jul;33(7):1275-1286. doi: 10.1002/oby.24308. Epub 2025 Jun 15.

DOI:10.1002/oby.24308
PMID:40518490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12210094/
Abstract

OBJECTIVE

This study aimed to explore the dynamic role of bile acids (BAs) in metabolic improvements following bariatric surgery, specifically comparing the effects of silastic ring laparoscopic Roux-en-Y gastric bypass (SR-LRYGB) and laparoscopic sleeve gastrectomy (LSG) on BA composition and clinical parameters over a 5-year period.

METHODS

A cohort of patients with obesity and type 2 diabetes underwent SR-LRYGB or LSG. Principal component analysis was performed to evaluate BAs and clinical outcomes.

RESULTS

Despite significant increases in the first year after surgery, BA levels returned to baseline after 5 years. However, principal component analysis revealed that certain BA profiles may contribute to long-term metabolic benefits.

CONCLUSIONS

Although total BA levels return to baseline by 5 years after surgery, specific BA profiles, as identified by principal component analysis from oral glucose tolerance test data, are associated with sustained metabolic improvements. SR-LRYGB is associated with more durable metabolic benefits compared with LSG. However, given the use of the oral glucose tolerance test, which may not fully capture postprandial BA dynamics, further research using mixed-meal tolerance tests is needed to confirm these findings.

摘要

目的

本研究旨在探讨胆汁酸(BAs)在减肥手术后代谢改善中的动态作用,特别是比较硅胶环腹腔镜Roux-en-Y胃旁路术(SR-LRYGB)和腹腔镜袖状胃切除术(LSG)在5年期间对BA组成和临床参数的影响。

方法

一组肥胖和2型糖尿病患者接受了SR-LRYGB或LSG手术。进行主成分分析以评估BAs和临床结果。

结果

尽管术后第一年BA水平显著升高,但5年后BA水平恢复到基线。然而,主成分分析显示,某些BA谱可能有助于长期代谢益处。

结论

虽然术后5年总BA水平恢复到基线,但通过口服葡萄糖耐量试验数据的主成分分析确定的特定BA谱与持续的代谢改善相关。与LSG相比,SR-LRYGB与更持久的代谢益处相关。然而,鉴于使用了口服葡萄糖耐量试验,其可能无法完全捕捉餐后BA动态,需要使用混合餐耐量试验进行进一步研究以证实这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb7d/12210094/88cc3ca30985/OBY-33-1275-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb7d/12210094/2cb2349b87c7/OBY-33-1275-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb7d/12210094/88cc3ca30985/OBY-33-1275-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb7d/12210094/2cb2349b87c7/OBY-33-1275-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb7d/12210094/88cc3ca30985/OBY-33-1275-g001.jpg

相似文献

1
Beyond weight loss: exploring bile acid modulations after bariatric surgery and their impact on type 2 diabetes across 5 years.超越体重减轻:探索减肥手术后胆汁酸的调节及其对2型糖尿病的5年影响。
Obesity (Silver Spring). 2025 Jul;33(7):1275-1286. doi: 10.1002/oby.24308. Epub 2025 Jun 15.
2
Long-term and midterm outcomes of laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass: a systematic review and meta-analysis of comparative studies.腹腔镜袖状胃切除术与Roux-en-Y胃旁路术的长期和中期结局:比较研究的系统评价和荟萃分析
Surg Obes Relat Dis. 2017 Feb;13(2):170-180. doi: 10.1016/j.soard.2016.08.011. Epub 2016 Aug 18.
3
Diabetes improvement and resolution following laparoscopic vertical sleeve gastrectomy (LVSG) versus laparoscopic Roux-en-Y gastric bypass (LRYGB) procedures: a systematic review of randomized controlled trials.腹腔镜垂直袖状胃切除术(LVSG)与腹腔镜Roux-en-Y胃旁路术(LRYGB)术后糖尿病的改善与缓解:一项随机对照试验的系统评价
Surg Endosc. 2017 Apr;31(4):1952-1963. doi: 10.1007/s00464-016-5202-5. Epub 2016 Sep 13.
4
Long-term effect of Roux-en-Y gastric bypass versus sleeve gastrectomy on reflux and Barrett's oesophagus: a randomized controlled trial.Roux-en-Y胃旁路术与袖状胃切除术对反流和巴雷特食管的长期影响:一项随机对照试验。
ANZ J Surg. 2025 May;95(5):911-918. doi: 10.1111/ans.19369. Epub 2025 Jan 19.
5
Acute Changes of Bile Acids and FGF19 After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass.袖状胃切除术和 Roux-en-Y 胃旁路术后胆汁酸和 FGF19 的急性变化。
Obes Surg. 2019 Nov;29(11):3605-3621. doi: 10.1007/s11695-019-04040-x.
6
Prepregnancy Roux-en-Y gastric bypass vs sleeve gastrectomy: a systematic review, pairwise, and network meta-analysis of obstetrical and neonatal outcomes.孕前 Roux-en-Y 胃旁路术与袖状胃切除术:产科和新生儿结局的系统评价、成对比较和网络荟萃分析。
Am J Obstet Gynecol MFM. 2023 Jun;5(6):100914. doi: 10.1016/j.ajogmf.2023.100914. Epub 2023 Mar 7.
7
A review of laparoscopic sleeve gastrectomy for morbid obesity.腹腔镜袖状胃切除术治疗病态肥胖的综述。
Obes Surg. 2010 Aug;20(8):1171-7. doi: 10.1007/s11695-010-0145-8.
8
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.减肥手术治疗肥胖症的临床疗效和成本效益:一项系统评价与经济评估
Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410.
9
Comparison of metabolic outcomes in patients undergoing laparoscopic roux-en-Y gastric bypass versus sleeve gastrectomy - a systematic review and meta-analysis of randomised controlled trials.腹腔镜Roux-en-Y胃旁路手术与袖状胃切除术患者代谢结局的比较——一项随机对照试验的系统评价和荟萃分析
Swiss Med Wkly. 2018 Jul 5;148:w14633. doi: 10.57187/smw.2018.14633. eCollection 2018.
10
EAES rapid guideline: systematic review, network meta-analysis, CINeMA and GRADE assessment, and European consensus on bariatric surgery-extension 2022.EAES 快速指南:系统评价、网络荟萃分析、CINeMA 和 GRADE 评估以及 2022 年肥胖手术扩展的欧洲共识。
Surg Endosc. 2022 Mar;36(3):1709-1725. doi: 10.1007/s00464-022-09008-0. Epub 2022 Jan 20.

本文引用的文献

1
Comparing Safety and Efficacy Outcomes of Gastric Bypass and Sleeve Gastrectomy in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.胃旁路手术与袖状胃切除术治疗2型糖尿病患者的安全性和疗效结果比较:一项系统评价和荟萃分析
Cureus. 2024 Jan 23;16(1):e52796. doi: 10.7759/cureus.52796. eCollection 2024 Jan.
2
The Impact of Bariatric Surgery on Weight Loss and Glycemic Control in Patients With Obesity and Type 2 Diabetes: A Systematic Review.减重手术对肥胖合并2型糖尿病患者体重减轻及血糖控制的影响:一项系统评价
Cureus. 2023 Nov 20;15(11):e49122. doi: 10.7759/cureus.49122. eCollection 2023 Nov.
3
Research Progress of Takeda G Protein-Coupled Receptor 5 in Metabolic Syndrome.
特科拉 G 蛋白偶联受体 5 在代谢综合征中的研究进展。
Molecules. 2023 Aug 4;28(15):5870. doi: 10.3390/molecules28155870.
4
Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity.肥胖的医学和手术治疗方法对代谢组学、脂质和脂蛋白的早期变化的影响。
Metabolism. 2023 Jan;138:155346. doi: 10.1016/j.metabol.2022.155346. Epub 2022 Nov 12.
5
Effect of Banded Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy on Diabetes Remission at 5 Years Among Patients With Obesity and Type 2 Diabetes: A Blinded Randomized Clinical Trial.带襻 Roux-en-Y 胃旁路术与袖状胃切除术对肥胖合并 2 型糖尿病患者糖尿病缓解的 5 年影响:一项盲法随机临床试验。
Diabetes Care. 2022 Jul 7;45(7):1503-1511. doi: 10.2337/dc21-2498.
6
Neurohormonal Changes in the Gut-Brain Axis and Underlying Neuroendocrine Mechanisms following Bariatric Surgery.减肥手术后肠道-脑轴的神经激素变化及潜在神经内分泌机制
Int J Mol Sci. 2022 Mar 19;23(6):3339. doi: 10.3390/ijms23063339.
7
The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer.法尼醇 X 受体在代谢性疾病、胃肠道癌和肝癌中的作用。
Nat Rev Gastroenterol Hepatol. 2021 May;18(5):335-347. doi: 10.1038/s41575-020-00404-2. Epub 2021 Feb 10.
8
Changes in fasting bile acid profiles after Roux-en-Y gastric bypass and sleeve gastrectomy.Roux-en-Y胃旁路术和袖状胃切除术后空腹胆汁酸谱的变化。
Medicine (Baltimore). 2021 Jan 22;100(3):e23939. doi: 10.1097/MD.0000000000023939.
9
Diversity and versatility of p38 kinase signalling in health and disease.p38 激酶信号在健康和疾病中的多样性和多功能性。
Nat Rev Mol Cell Biol. 2021 May;22(5):346-366. doi: 10.1038/s41580-020-00322-w. Epub 2021 Jan 27.
10
Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism.肝细胞激活转录因子 3 通过调节高密度脂蛋白和胆汁酸代谢来保护动脉粥样硬化。
Nat Metab. 2021 Jan;3(1):59-74. doi: 10.1038/s42255-020-00331-1. Epub 2021 Jan 18.